Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Hugosson

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Urology|August 2, 2003
Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infectionBjörn Zackrisson, Peter Ulleryd, Gunnar Aus, et al.
Scandinavian Journal of Urology and Nephrology|May 31, 2003
Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy?--A case control studyAli Khatami, Jan-Erik Damber, Pär Lodding, et al.
The Journal of Urology|May 7, 2018
Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active SurveillanceRebecka Arnsrud Godtman, Max Schafferer, Carl-Gustaf Pihl, et al.
European Urology|January 22, 2004
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratioGunnar Aus, Charlotte Becker, Stefan Franzén, et al.
Acta Oncologica (Stockholm, Sweden)|August 27, 2005
Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?Ali Khatami, Carl-Gustaf Pihl, Klas Norrby, et al.
Scandinavian Journal of Urology and Nephrology|November 5, 2003
Radical prostatectomy--long-term oncological outcome from a community hospitalMaria Tol-Fakkar, Carl Gustaf Hermansson, Jonas Hugosson, et al.
European Urology|March 15, 2024
Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening TrialFredrik Möller, Marianne Månsson, Jonas Wallström, et al.
Journal of the National Cancer Institute|June 22, 2010
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up studyPär Stattin, Erik Holmberg, Jan-Erik Johansson, et al.
The Journal of Urology|October 22, 2008
Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of SwedenPär Stattin, Erik Holmberg, Ola Bratt, et al.
European Urology|April 2, 2003
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screeningBjörn Zackrisson, Gunnar Aus, Hans Lilja, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Urology|August 2, 2003
Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infectionBjörn Zackrisson, Peter Ulleryd, Gunnar Aus, et al.
Scandinavian Journal of Urology and Nephrology|May 31, 2003
Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy?--A case control studyAli Khatami, Jan-Erik Damber, Pär Lodding, et al.
The Journal of Urology|May 7, 2018
Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active SurveillanceRebecka Arnsrud Godtman, Max Schafferer, Carl-Gustaf Pihl, et al.
European Urology|January 22, 2004
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratioGunnar Aus, Charlotte Becker, Stefan Franzén, et al.
Acta Oncologica (Stockholm, Sweden)|August 27, 2005
Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?Ali Khatami, Carl-Gustaf Pihl, Klas Norrby, et al.
Scandinavian Journal of Urology and Nephrology|November 5, 2003
Radical prostatectomy--long-term oncological outcome from a community hospitalMaria Tol-Fakkar, Carl Gustaf Hermansson, Jonas Hugosson, et al.
European Urology|March 15, 2024
Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening TrialFredrik Möller, Marianne Månsson, Jonas Wallström, et al.
Journal of the National Cancer Institute|June 22, 2010
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up studyPär Stattin, Erik Holmberg, Jan-Erik Johansson, et al.
The Journal of Urology|October 22, 2008
Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of SwedenPär Stattin, Erik Holmberg, Ola Bratt, et al.
European Urology|April 2, 2003
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screeningBjörn Zackrisson, Gunnar Aus, Hans Lilja, et al.
Pageof 18